AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...
There are other reasons to pay attention to Viking Therapeutics.
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other ...
AbCellera (Nasdaq: ABCL) today announced a collaboration with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) to research, develop, manufacture, and commercialize multispecific T-cell engagers ...
CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...
Biogen has found a successor to longtime legal chief Susan Alexander, tapping former Vertex Pharmaceuticals executive and ...
MarketBeat on MSN
Vertex Pharmaceuticals bets $10 billion on Crinetics to build endocrinology powerhouse
Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash, valuing the ...
A seasoned leader in refining, renewable fuels, and clean-energy infrastructure joins Alléo as it scales its proprietary ...
WSW, NY, July 22nd, 2026, FinanceWireTen billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay ...
Vertex, Inc. ( (VERX)) has released its Q3 earnings. Here is a breakdown of the information Vertex, Inc. presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...
In a widely circulated essay published on July 12, Microsoft (MSFT 1.67%) CEO Satya Nadella identified a fundamental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results